Genome & Company Board Resolves to Convene Temporary Shareholders Meeting with Details to Follow
The board of directors resolved to convene a temporary shareholders' meeting scheduled for August 21, 2026.
Specific details such as the venue and agenda items will be determined and disclosed by the board at a later date.
An electronic voting system will be introduced and implemented, with detailed instructions to be provided in the subsequent notice of meeting.
Authority for convening notices and other procedural matters has been delegated to the CEO.
[AI Summary]The resolution to convene a temporary shareholders' meeting by Genome & Company is an administrative milestone that confirms the schedule and procedures, with no direct impact on shareholder value such as capital changes or dividends at this stage. Investors should closely monitor subsequent disclosures for the specific agenda items.
KOSDAQ Filing Information
Resolution to Convene a General Meeting of Shareholders (Extraordinary General Meeting)